News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
First-Line Procarbazine, CCNU, and Vincristine With Radiotherapy in IDH-Mutant Oligodendroglioma – Journal of Clinical Oncology
 Salah Eddine O. Kacimi/researchgate.net
Oct 15, 2024, 16:40

First-Line Procarbazine, CCNU, and Vincristine With Radiotherapy in IDH-Mutant Oligodendroglioma – Journal of Clinical Oncology

Journal of Clinical Oncology shared a post on X:

“Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.”

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma

Authors: Salah Eddine O. Kacimi, et al.

 

First-Line Procarbazine, CCNU, and Vincristine With Radiotherapy in IDH-Mutant Oligodendroglioma - Journal of Clinical Oncology

cancer cancer awareness cancer care CCNU fight against cancer Global fight against cancer JCO Journal of Clinical Oncology Oligodendroglioma OncoDaily Oncology Procarbazine radiotherapy Salah Eddine O. Kacimi
Special Coverage
Blog
Mar 29, 2025, 13:57
Introducing The Lancet Obstetrics, Gynaecology, and Women’s Health Journal - The Lancet
Blog
Mar 29, 2025, 13:29
Bilal Awad: My Blog about Colorectal Cancer Awareness Month - A Call to Action
Blog
Mar 29, 2025, 13:09
Tedros Adhanom Ghebreyesus: The 2nd WHO Global Conference on Air Pollution and Health
Blog
Mar 29, 2025, 12:57
Hidehito Horinouchi: COCOON trial on preventing dermatologic adverse events in EGFR-mutant NSCLC
Blog
Mar 29, 2025, 12:32
Flavio Rocha: Inspiring presidential address by Ronald de Matteo at SSO2025
Blog
Mar 29, 2025, 12:27
Catherine Alix-Panabières: Honored to moderate at ESMO European Lung Cancer Congress 2025
Blog
Mar 29, 2025, 12:06
Loay Kassem: Who should be the first author of the manuscript?
Insight
Mar 29, 2025, 12:00
Surgery may not be necessary to treat invasive breast cancer
Blog
Mar 29, 2025, 11:58
Uta Schmidt-Straßburger: Insights from the Digital Health Innovation Forum
Radiotherapy
Mar 29, 2025, 11:54
Is Brachytherapy Right for You? The Science, Benefits, and Drawbacks Explained
Societies
Mar 29, 2025, 11:36
Patient-Reported Outcomes: ASCO Guideline is now available for Open Comment
Blog
Mar 29, 2025, 11:26
Insights from Axios' 4th Annual What's Next Summit by Lisa A. Lacasse